Sign in

CIK 0001604821 · Large accelerated filer

Natera, Inc.

Sign in to watch
Ticker
NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
010894487
Phone
650-249-9090
Business address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
Former names
Natera, Inc.
  1. 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,000 shares at an average $199.85 ($599,545)
  2. 4 Grant or award EXECUTIVE CHAIRMAN acquired 29,920 shares (grant or award)
  3. 4 Grant or award SEC. AND CHIEF LEGAL OFFICER acquired 12,272 shares (grant or award)
  4. 4 Grant or award PRESIDENT, CHIEF BUS. OFFICER acquired 10,051 shares (grant or award)
  5. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 10,051 shares (grant or award)
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. 10-K Report Annual Report
  10. 8-K Event Results of operations
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 4,639 shares at an average $231.20 ($1,072,538)
  13. 4 Planned sale CEO AND PRESIDENT sold 90,024 shares at an average $230.72 ($20,770,419)
  14. 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,939 shares at an average $227.83 ($1,580,926)
  15. 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 3,594 shares at an average $231.02 ($830,279)
  16. 4 Planned sale Director sold 435 shares at $230.77 ($100,384)
  17. 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 1,334 shares at $230.77 ($307,845)
  18. 4 Grant or award PRESIDENT, CHIEF BUS. OFFICER acquired 6,135 shares (grant or award)
  19. 4 Grant or award Director acquired 73 shares (grant or award)
  20. 4 Grant or award Director acquired 99 shares (grant or award)

Page 12 of 94 · 1,862 filings